A Novel Tetravalent Dengue Vaccine Is Well Tolerated and Immunogenic against All 4 Serotypes inFlavivirus‐Naive Adults
Year: 2010
Type: article
Study design: Clinical Trial
DOI: 10.1086/649916
Institutions: Sanofi (France), Mahidol University
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Sanofi Pasteur
OpenAlex ID: W2086448648
